Who is sponsoring NCT05334550?

NCT05334550 is sponsored by Samsung Medical Center.

What drugs are being tested in NCT05334550?

Interventions in NCT05334550: Home Based Early Intervention by Parent.

What condition does NCT05334550 study?

NCT05334550 studies Preterm, Extreme Prematurity, Early Intervention, Developmental Delay, Motor Outcome, Home Exercise, Parents.

Is NCT05334550 still recruiting?

NCT05334550 is currently status unknown. Last updated 8 June 2022.

Last reviewed 2022-06-08 · How we verify

NCT05334550

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Home Based Early Intervention of Extremely Premature Infant by Parent

Status unknown NA Last updated 8 June 2022

What this trial tests

NA trial testing Home Based Early Intervention by Parent in Preterm in 110 participants. Status unknown.

Timeline

2 June 2022

Primary endpoint
2 March 2023

2 March 2024

Quick facts

Lead sponsor	Samsung Medical Center
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	110
Start date	2 June 2022
Primary completion	2 March 2023
Estimated completion	2 March 2024

Drugs / interventions tested

Home Based Early Intervention by Parent

Conditions studied

Preterm — all drugs for Preterm →
Extreme Prematurity — all drugs for Extreme Prematurity →
Early Intervention — all drugs for Early Intervention →
Developmental Delay — all drugs for Developmental Delay →

Sponsor

Samsung Medical Center

Who can join

Eligibility, any sex, with Preterm or Extreme Prematurity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is to prove the effectiveness of home based early intervention of extremely premature infant by Parent.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Early developmental intervention programmes provided post hospital discharge to prevent motor and cognitive impairment in preterm infants.
Orton J, Doyle LW, Tripathi T, Boyd R, et al · · 2024 · cited 37× · PMID 38348930 · DOI 10.1002/14651858.cd005495.pub5

Verify or expand the search:

Other recruiting trials for Preterm

Currently open trials in the same condition.

NCT03736707 — High-Frequency Oscillation Ventilation Versus Conventional Mechanical Ventilation in Very Preterm Infants With Perinatal · NA · recruiting
NCT07201805 — Effects of Early Physiotherapy on Motor Optimality Score in At-Risk of Infants · NA · recruiting
NCT07061366 — The Use of the Bambi-Belt in Exteremly Preterm Infants: an Implementation Study. · recruiting
NCT07068581 — Effect of Maternal Voice on Physiological Indicators and Feeding Performance · NA · recruiting
NCT07192393 — Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocoliti · recruiting

Other Samsung Medical Center trials

Trials by the same sponsor.

NCT07482865 — Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support · NA · not yet recruiting
NCT07467213 — Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute M · Phase 4 · not yet recruiting
NCT07530913 — Effectiveness Analysis of a Rehabilitation Exercise Platform for Living Donor Liver Transplantation Patients · NA · enrolling by invitation
NCT07500701 — Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Pro · Phase 3 · recruiting
NCT07409441 — Korea Acute Myocardial Infarction Registry · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05334550 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Samsung Medical Center
Last refreshed: 8 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05334550.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing